Merit Medical Systems Inc header image

Merit Medical Systems Inc

MMSI

Equity

ISIN null / Valor 951136

NASDAQ (2025-11-21)
USD 87.20+2.73%

Merit Medical Systems Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Merit Medical Systems Inc, established in 1987, is a prominent manufacturer and distributor of disposable medical devices utilized in various interventional, diagnostic, and therapeutic procedures, with a focus on cardiology, radiology, oncology, critical care, and endoscopy. The company caters to hospitals and physicians globally, boasting a workforce of around 7,000 employees.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (19.11.2025):

Merit Medical Systems Inc reported strong Q3 2025 financial results, demonstrating solid revenue growth and profitability improvements versus Q3 2024. The company achieved a reported revenue of $384.2 million, a 13% increase year-over-year, supported by improvements in constant currency revenue, margins, and robust free cash flow generation over the first nine months of 2025.

Revenue Growth

For the third quarter of 2025, Merit Medical Systems Inc recorded $384.2 million in revenue, up 13% compared to the same quarter in 2024. Constant currency revenue increased by 12.5%, with organic constant currency revenue rising by 7.8%.

Profitability & Margins

Margins continued to improve with a GAAP operating margin of 11.1% (up slightly from 11.0%) and a non-GAAP operating margin of 19.7%, compared to 19.2% in Q3 2024. The GAAP gross margin increased to 48.5% from 46.4%, while non-GAAP gross margin improved to 53.6% from 50.9%.

Earnings Per Share

Merit reported a GAAP EPS of $0.46—a 3% decline compared to Q3 2024—while non-GAAP EPS improved to $0.92, up 6.7% from the prior year period.

Cash Flow Performance

The company generated $141.6 million in free cash flow over the first nine months of 2025, marking a 17.6% year-over-year increase. This strong cash performance supports its ongoing financial health and execution of growth initiatives.

Summarized from source with an LLMView Source

Key figures

-17.0%1Y
23.4%3Y
65.5%5Y

Performance

30.5%1Y
27.7%3Y
29.7%5Y

Volatility

Market cap

5164 M

Market cap (USD)

Daily traded volume (Shares)

766,706

Daily traded volume (Shares)

1 day high/low

97.21 / 95.94

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Straumann Holding Ltd
Straumann Holding Ltd Straumann Holding Ltd Valor: 117544866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.30%CHF 96.58
National Healthcare Corp
National Healthcare Corp National Healthcare Corp Valor: 836282
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.42%USD 130.44
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%EUR 1.05
Dyne Therapeutics Inc
Dyne Therapeutics Inc Dyne Therapeutics Inc Valor: 56806425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.27%USD 21.18
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.11%USD 18.31
COSMO Pharmaceuticals N.V.
COSMO Pharmaceuticals N.V. COSMO Pharmaceuticals N.V. Valor: 32590356
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%CHF 67.10
Astrana Health Inc
Astrana Health Inc Astrana Health Inc Valor: 28041888
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
10.62%USD 22.50
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252587
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.09%DKK 44.18
Embla Medical hf
Embla Medical hf Embla Medical hf Valor: 1060135
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.20%DKK 33.80
MannKind Corp
MannKind Corp MannKind Corp Valor: 35935511
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 5.03